Drug Effect Clinical Trial
Official title:
Propolis-based Nanovesicles as Oromuco-adhesive Film: Novel Therapeutic Drug Delivery System for Treatment of Oral Recurrent Aphthous Ulcer
A total of 24 patients suffering from RAU, they were divided into two groups each included 12 patients. The first group was treated by the propolis mucoadhesive film and the second group received the film without the active component (placebo group).Patients were handed a checklist for monitoring the actual improvement of the clinical parameters which included; duration of disappearance of pain after film application (hours), duration of complete healing of the aphthous ulcer (weeks), onset of ulcer size reduction after film application (days), duration of propolis film adherence onto the oral mucosa (hours) and finally the level of patient satisfaction scaled from 1-10.
The present study have been performed on a total of 24 patients suffering from RAU, they were
divided into two groups each included 12 patients. The first group was treated by the
propolis mucoadhesive film and the second group received the film without the active
component (placebo group). Patients were recruited from the out-patient clinic of the Faculty
of Dentistry, British University in Egypt during a period of 6 months.
Patients were subjected to thorough clinical examination and history obtaining in order to
diagnose the oral ulcer by an oral medicine specialist, they were thoroughly informed about
the study and only those with the oral ulcer within the first day to the third day of
appearance were included in the present study.
The exclusion criteria in the present study were the presence of systemic or local disease
such as hepatitis, cardiac conditions, hypertension, diabetes mellitus, renal problems,
mental disorders, AIDS and also the use of any immunosuppressive drugs or systemic
corticosteroids during last three months or using steroid treatment locally in last month,
also any nutritional supplements, folic acid or antioxidants, pregnancy and nursing.
All patients were asked to avoid using antiseptics, antibiotics or analgesics, during the
study as they might aid in curing the oral ulcers. Patients were blinded of receiving either
propolis or placebo. They were warned about the potentiality of allergic responses that could
happen to some people and that in case of occurrence of such side effect immediate
termination of using the film should be implemented.
The patients were first instructed how to apply the mucoadhesive film of 2 cm2 on the oral
ulcer and pasted by applying a light force with the finger tip for 20 s, and then were asked
to apply it two times per day and to refrain from eating for at least one hour after the film
application on the oral ulcer.
Patients were handed a checklist for monitoring the actual improvement of the clinical
parameters which included; duration of disappearance of pain after film application (hours),
duration of complete healing of the aphthous ulcer (weeks), onset of ulcer size reduction
after film application (days), duration of propolis film adherence onto the oral mucosa
(hours) and finally the level of patient satisfaction scaled from 1-10. After total healing
of the oral RAU, checklists were recollected from patients, the results were tabulated and
statistical analysis were conducted.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04235894 -
An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
|
||
Completed |
NCT04166890 -
Comparison of the Efficacy and Safety of Two Homologous Active Principles for Local Dental Anesthesia
|
Phase 4 | |
Completed |
NCT03265613 -
Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis
|
Phase 1/Phase 2 | |
Recruiting |
NCT04037774 -
Comparision of Different Doses of Dexmedetomidine With Low Dose Bupivacaine in Selective Spinal Anesthesia.
|
Phase 4 | |
Recruiting |
NCT05113420 -
The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
|
||
Completed |
NCT03801629 -
Neuroimmune Effects of Opioid Administration
|
Phase 1 | |
Completed |
NCT04052776 -
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
|
Phase 1 | |
Completed |
NCT04037085 -
Ketamine to Improve Recovery After Cesarean Delivery - Part 1
|
Phase 2 | |
Completed |
NCT05050071 -
Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination in Infected Mature Teeth
|
Phase 2/Phase 3 | |
Completed |
NCT03305666 -
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
|
Phase 4 | |
Completed |
NCT06238154 -
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
|
Phase 4 | |
Not yet recruiting |
NCT04392427 -
New Antiviral Drugs for Treatment of COVID-19
|
Phase 3 | |
Recruiting |
NCT05300152 -
Pulpotomy Medications in Primary Teeth
|
N/A | |
Recruiting |
NCT04594889 -
Comparison of Sirolimus vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
|
N/A | |
Not yet recruiting |
NCT05018936 -
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
|
Phase 2/Phase 3 | |
Completed |
NCT04245774 -
Comparing the Effects of Levobupivacaine and Bupivacaine in Saddle Spinal Anesthesia
|
Phase 4 | |
Completed |
NCT04449536 -
Cysteine-lowering Treatment With Mesna
|
Phase 1 | |
Recruiting |
NCT05975255 -
Dose Finding Study for Remimazolam in Children
|
Phase 2 | |
Active, not recruiting |
NCT04254731 -
Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals
|
Phase 4 | |
Completed |
NCT03635684 -
Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen
|
Phase 2 |